HomepageEarnings Events Newsdesk 30 minutes ago Merck & Co., Inc. (MRK) Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) Merck & Co., Inc. (NYSE: MRK) FY 2026 M&A Release Merck & Co., Inc. (MRK) Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) » « NOV Inc. (NOV) Announces Expansion of Subsea Flexible Pipe Manufacturing Capacity to Support Growing Demand Newsdesk:
